IPAD-DB ID | S01244 |
Name | Toluidine blue O |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 5 H 1 6 C l N 3 S |
Molecular Weight | 305.8 g/mol |
IUPAC Name | (7-amino-8-methylphenothiazin-3-ylidene)-dimethylazanium;chloride |
InChI | InChI=1S/C15H15N3S.ClH/c1-9-6-13-15(8-11(9)16)19-14-7-10(18(2)3)4-5-12(14)17-13;/h4-8, 16H, 1-3H3;1H |
InChIKey | GEDVVYWLPUPJJZ-UHFFFAOYSA-N |
Canonical SMILES | CC1=CC2=C(C=C1N)SC3=CC(=[N+](C)C)C=CC3=N2.[Cl-] |
PubChem CID | 7083 |
DrugBank Accession Number | - |
CAS Registry Number | - |
Molecular Weight(Computed by SwissADME) | 305.83 |
Hac(Computed by SwissADME) | 20 |
Volume(Computed by ADMETlab 2.0) | 276.689 |
Density(Computed by ADMETlab 2.0) | 0.976 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 14 |
nHet(Computed by ADMETlab 2.0) | 4 |
fChar(Computed by ADMETlab 2.0) | 1 |
nRig(Computed by ADMETlab 2.0) | 17 |
Flexibility(Computed by ADMETlab 2.0) | 0 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -1.576 |
LogD(Computed by ADMETlab 2.0) | 1.87 |
logP(Computed by ADMETlab 2.0) | 2.126 |
TPSA(Computed by SwissADME) | 70.16 |
Hbond Acceptor(Computed by SwissADME) | 1 |
Hbond Donor(Computed by SwissADME) | 1 |
Rotatable Bonds(Computed by SwissADME) | 0 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.32 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 1 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |